Ignite Creation Date:
2024-05-06 @ 10:06 AM
Last Modification Date:
2024-10-26 @ 12:24 PM
Study NCT ID:
NCT03164616
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-12
First Post:
2017-05-22
Brief Title:
Study of Durvalumab Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer POSEIDON
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2017-05-22
First Submit QC Date:
May 22 2017
Study First Post Date:
2017-05-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-04-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-12
Last Update Post Date:
2024-06-12
Last Update Post Date Type:
ACTUAL